seperator1-n

ABOUT US

Established in 1935 and with headquarters in the centre of Cambridge, the Howard Group is a leading regional property investor and developer. The Group also provides growth capital funding, strategic and management support to mid-sized businesses across a diverse range of sectors.

PROPERTY

The Howard Group has 80 years’ experience in the property sector. Today the Group holds some £100m of commercial property, predominantly in London and the East of England. It also has a £150m development pipeline, making it one of the Country’s pre-eminent privately owned regional developers.

CAPITAL

The Group is an experienced investor in companies across a broad range of sectors. It invests Howard Family equity in mid-sized established and profitable businesses that possess strong, dynamic management teams and show promising growth potential.

CASE STUDIES

NEWS

  • HOWARD GROUP BOLSTER TEAM WITH NEW HIRES

    Howard Group has strengthened its team with four new appointments to support the company’s continued growth. Robin Lea has been appointed as financial controller which involves overseeing the day-to-day running of the accounts department. Robin has significant experience in finance and has worked as a financial controller and management accountant for the last 14 years […]
    Read more...
  • CAMBRIDGE DEVELOPER SHORTLISTED FOR PRESTIGIOUS AWARD

    Howard Group’s Industrial Estate situated in New Bermondsey, London, has been shortlisted for ‘Best Overall Scheme – Multi Let Industrial Estate’ in the national IAS (Industrial Agents Society) awards. Located in one of London’s most dynamic growth areas, Elizabeth Industrial Estate provides some of the highest quality industrial premises in the area. Howard Group acquired […]
    Read more...
  • PIONEERING BIOTECH BUSINESS COMPLETES ICONIX 2 LINE UP

    Property Investors and developers Howard Group have taken further steps forward in their plan to bring some of the most forward-thinking and innovative businesses to Iconix Park in Sawston. The most recent occupier to sign up is biotechnology company IONTAS, who have taken the last space at Iconix 2. The pioneering therapeutic antibody discovery business […]
    Read more...